Similar articles

• Medical treatments for opioid use disorder in Iran: a randomized, double-blind placebo-controlled comparison of buprenorphine/naloxone and naltrexone maintenance treatment.

  Mokri A, Chawarski MC, Taherinakhost H, Schottenfeld RS. Mokri A, et al. Addiction. 2016 May;111(5):874-82. doi: 10.1111/add.13259. Epub 2016 Jan 26. Addiction. 2016. PMID: 26639678 Clinical Trial.
• Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study.

  Ling W, Hillhouse MP, Saxon AJ, Mooney LJ, Thomas CM, Ang A, Matthews AG, Hasson A, Annon J, Sparenborg S, Liu DS, McCormack J, Church S, Swafford W, Drexler K, Schuman C, Ross S, Wiest K, Korthuis PT, Lawson W, Brigham GS, Knox PC, Dawes M, Rotrosen J. Ling W, et al. Addiction. 2016 Aug;111(8):1416-27. doi: 10.1111/add.13375. Epub 2016 Apr 21. Addiction. 2016. PMID: 26948856 Free PMC article. Clinical Trial.
• Treatment of opioid dependence with buprenorphine/naloxone sublingual tablets: A phase 3 randomized, double-blind, placebo-controlled trial.

  Wang X, Jiang H, Zhao M, Li J, Gray F, Sheng L, Li Y, Li X, Ling W, Li W, Hao W. Wang X, et al. Asia Pac Psychiatry. 2019 Mar;11(1):e12344. doi: 10.1111/appy.12344. Epub 2018 Nov 20. Asia Pac Psychiatry. 2019. PMID: 30460781 Clinical Trial.
• Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.

  Tran TH, Griffin BL, Stone RH, Vest KM, Todd TJ. Tran TH, et al. Pharmacotherapy. 2017 Jul;37(7):824-839. doi: 10.1002/phar.1958. Epub 2017 Jul 2. Pharmacotherapy. 2017. PMID: 28543191 Review.
• Buprenorphine-naloxone buccal soluble film for the treatment of opioid dependence: current update.

  Soyka M. Soyka M. Expert Opin Drug Deliv. 2015 Feb;12(2):339-47. doi: 10.1517/17425247.2014.953479. Epub 2014 Aug 25. Expert Opin Drug Deliv. 2015. PMID: 25156759 Review.